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Spermatocytic seminoma (SS) is a rare testicular neoplasm characterized by a palpable, painless, slowly enlarging
mass in the testis. Even more rare is a synchronous bilateral presentation. Only eight cases of bilateral SS have been
reported in the literature, of which three cases were present with synchronous testis enlargement, and five were
sequential. Here, we report an additional case of synchronous bilateral SS and present a comprehensive relevant
literature review concerning clinical features, histopathology, and treatment.
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Spermatocytic seminoma (SS), a rare testicular neoplasm
differing from classical seminoma, usually presents in
older men (>50 years of age) and occurs only sporadic-
ally in younger men (<30 years of age) [1-3]. SS has no
equivalent ovarian carcinoma, is not associated with
other types of germ cell neoplasia, and is not found in
cases of cryptorchidism [4]. Depending on the different
series, it represents 2 to 12% of all seminomas [5]. Since
the first case of SS was described by Masson more than
50 years ago [6], more than 200 cases have been
reported, most of them benign [7]. It is a solid tumor
found solely in the testis with long duration of symp-
toms, presentation evident at an early stage, absence of
metastasis, and bears an excellent prognosis [8]. More-
over, SS arises more commonly in the right testis, and
has a higher frequency of bilateral occurrence than clas-
sical seminoma [9]. Following a thorough review of the
literature, we have found only eight reported cases of
bilateral SS. Herein, we report an additional case of
bilateral SS and present a relevant review of the litera-
ture concerning clinical features, histopathology, and
treatment.* Correspondence: whl1228@126.com
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A 48-year-old man presented in June 2011 complaining
of gradually increasing left testicular painless swelling
for 2 years. For the immediate 2 previous months, he
found his right testicle enlarging rapidly. There was no
history of cryptorchidism, bilateral scrotal pain, voiding
complaints, local trauma, weight loss, or hereditary
disease. A comprehensive physical examination revealed
bilateral testis enlargement and displayed firm consist-
encies to palpation. A huge, well-defined, non-tender,
left testicular mass was palpable in the scrotum. The
patient’s right testicle had similar palpatory findings as
his left testicle, while his inguinal lymph nodes were not
palpable. Scrotal ultrasonography (8 to 12 linear array
transducer, TOSHIBA NemioXG, Tokyo, Japan) revealed
a well-defined 75 × 45 × 40 mm left testicular multilocular
tumor and an 80 × 50 × 45 mm right testicular solid tumor
with heterogeneous echogenicity (Figure 1). Computed
tomography of the abdomen and pelvis was negative for
lymphadenopathy or other metastases. Clinically, the pre-
operative diagnosis was bilateral testicular tumor, with the
possibility of classical seminoma.
Taking into account the age of the patient, fine-needle
aspiration cytology (FNAC) was performed. The cyto-
logical smear revealed malignant tumor cells present in
both testes with bloody fluid background (Figure 2).
The tumor markers alpha-fetoprotein, human chorionic
gonadotropin, and serum lactate dehydrogenase were
within normal limits. The patient then underwent leftThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Scrotal ultrasonography of bilateral SS. (a) A left
testicular multilocular tumor, (b) a right testicular solid tumor.
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intraoperative frozen-section biopsy revealed SS. Subse-
quently, a right radical orchiectomy to remove the tes-
ticle was performed.
On gross examination, the left testicle measured 7 ×
4 × 3 cm and weighed 108 g, while the right testicle
measured 7 × 4 × 4 cm and weighed 118 g. Both masses
had fleshy, pale-grey cut surfaces and were confined to
the testis with no invasion or penetration of the tunica.
There were no overlying skin changes. A histological
examination confirmed the SS (Figures 3 and 4) and all
surgical margins were not infiltrated. Immunohisto-
chemical analysis revealed the tumor cells were positive
for CD117 and Ki-67 (50% stain positively), and negativeFigure 2 Scrotal ultrasound fine-needle aspiration cytology
revealed giant cells with large nuclei and coarse chromatin
(long arrow). Some intermediate-sized cells were noted
(short arrow).for CD3, CD20, CD30, placental-like alkaline phosphat-
ase (PLAP), OCT3/4, S-100, and HMB45 (Figure 5). The
data collected from immunohistochemical and histo-
logical analyses were consistent with the final pathologic
diagnosis of bilateral SS.
Following the operation, the patient was followed
closely without any adjuvant therapy and was in good
condition with no evidence of metastasis 18 months
after the operation.
Discussion
SS is a distinctive, uncommon testicular germ cell neo-
plasm, first described by Masson in 1946 [6]. An extensive
literature review revealed that the incidence of SS varies
between 1.1 and 12% of all seminomas [4,10] and 1% of all
testicular neoplasms [11]. The incidence of bilaterality,
either synchronous or metachronous, is nearly 10% of
cases [12]. To date, eight cases of bilateral SS have been
reported, including one from India [13], four from Japan
[14], and three from the USA [10,15,16]. We present the
first case review of bilateral SS, including patient age,
symptom duration, tumor size, treatment, and out-
comes (Table 1).
SS is found exclusively in the testis and is not associ-
ated with any known risk factors for germ cell tumors
including cryptorchidism, subfertility, or gonadal dys-
genesis [10]. These tumors originate from a post-natal
germ cell [12]. The detection of proteins SCP1 and
XPA, which are normally expressed in the primary and
pachytene spermatocyte stages, provide a clue that the
origin of SS is in a more differentiated cell than in clas-
sical seminoma [17]. The gain of chromosome 9 appears
to be a consistent finding in all cases of SS, which is not
found in classic seminomas; in addition, other genetic
abnormalities include gain of X chromosome. A recent
study confirmed that DMRT1, a male-specific transcrip-
tional regulator, was a likely candidate gene for involve-
ment in the development of SS [18]. Most cases of SS
present as a palpable, painless, slowly enlarging mass in
the testis; only one patient was referred because of
massive hemorrhage to hydrocele and needed emer-
gency management [19]. SS usually occurs in older
white men, in their sixth decade of life. Specifically,
Chung and colleagues reported the median age of pa-
tients with SS was 62 years (range 32 to 77 years) [10].
Raiss and colleagues found the median age to be 45 years
[11] and Carrière and colleagues found SS occurred just
as frequently in young men as in older men (median age
54 years) [5]. Our review indicated the median age of bi-
lateral SS was 55.1 years (range 28 to 77 years), with
only one patient presenting at the much younger age of
28 years of age [16]. Therefore, while rare, the diagnosis
should be considered even in young patients. Of the eight
reported cases, three were present with synchronous testis
a b
Figure 3 Low-power photomicrograph of SS showing minimal to no lymphocytic infiltration. (a) Less adhesion and interstitium among
cells as well as extensive edema are observed by H&E staining (×40). (b) Spermatocytic seminoma infiltrating the seminiferous tubules (×100).
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age duration of onset was 35.5 months on the left testicle
(range 1 to 108 months) and 30.3 months on the right tes-
ticle (range 1 to 108 months). Macroscopically, SS pre-
sents grossly as a testicular mass with a size ranging from
1.5 to 28 cm [20] and is generally a homogenous, well-
circumscribed, solid, pale-grey or pink-tan tumor that is
always confined to the testis. However, the rhabdo-
myosarcomatous transformation was seen infiltrating and
destroying the rete testis and epididymis [21]. Matoska
and Talerman reported that six SS patients with sarcoma
developed metastatic disease, and the metastases most fre-
quently affected the lung, liver, and retroperitoneum [22].
In our review, all tumors were classical SS and confined to
the testis. The tumor size ranged from 36 to 130 mm with
an average of 73.4 mm on the left and from 25 to 100 mm
with an average of 58.6 mm on the right.Figure 4 High-power photomicrograph of bilateral SS. Three
types of cells were noted: large cells having characteristic ‘spermine’
chromatin with filamentous nuclear structure (long arrow);
intermediate-sized cells which exhibit a finely granular chromatin
with eosinophilic cytoplasm (short arrow) and small lymphocyte-like
cells with scanty cytoplasm and a round nucleus (arrow head) (×40).Histopathologically, the presence of sheets and cords
of a mixture of different sized cells characterize SS with
similarities to spermatogonia and spermatocytes [23].
These often have the typical spireme-like lacy chromatin
distribution. Intermediate and large cells may have fila-
mentous nuclear chromatin. The nuclei of all the cell
types of SS are generally round or slightly oval and with
a smooth contour, in contrast with the nuclei of classical
seminoma cells, which are generally described as irregu-
larly shaped and “squared-off” [20]. There are many case
reviews or case reports that have described unilateral SS
associated with rhabdomyosarcomatous or sarcomatous
differentiation and anaplastic variant [6,7,20-22,24]. How-
ever, bilateral sarcomatous transformation have never
been reported. In this case report, three populations of
cells and a preponderance of intermediate-sized cells were
noted in a clean background, with small cells with a dense
hyperchromatic lymphocyte-like nuclei also present.
In most cases, classical seminomas show diffuse posi-
tivity for CD117, PLAP, and OCT4. However, many of
the markers useful in other types of germ cell tumor are
generally negative in SS [25]. Positive c-Kit (also known
as CD117) staining is controversial. While Raiss and col-
leagues showed four cases of SS were all negative for
CD117 [11], Decaussin and colleagues found c-Kit was
expressed in 100% of seven SS cases [26]. C-Kit positiv-
ity was also shown by Dundr and colleagues [6] and
Narang and colleagues [21]. In total, c-Kit is positive in
around 40% of all cases in the literature, a number consist-
ent with our findings in this study. P53 overexpression
may be involved in the pathogenesis anaplastic SS, due to
evidence in two cases in a study [24]. However, this
hypothesis needs molecular pathology confirmation. The
Ki-67 index, the proliferative activity with monoclonal
antibody MIB-1, may show nuclear positivity in about
10% of tumor cells and 30 to 40% of tumor cells in areas
with anaplastic features [6]. In our case, the Ki-67 index




Figure 5 Immunostaining of SS. (a) Spermatocytic seminoma cells show cytoplasmic positivity with CD117 (×400), (b) negativity with OCT3/4
(×200x), (c) negativity with placental-like alkaline phosphatase (×200), and (d) negativity with CD30 (×100).
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usually more intense in the latter [27].
A preoperational SS diagnosis is unlikely due to its
rarity and similarity with classical seminoma. Saran and
colleagues applied FNAC to diagnose a case of SS andTable 1 Characteristics and clinical course of published cases
Case No. Age (years) Duration of symptoms
(month)
Size or tumor l
110 68 NA L.s 45 mm
NA R.s 53 mm
213 50 60 L.s 130 × 80
18 R.s 50 × 40 ×
314 70 4 L.s 50 × 35 ×
1 R.s 52 × 45 ×
414 49 1 L.s 50 × 40 ×
2 R.s 60 × 45 ×
514 50 60 L.s 80 × 60 ×
60 R.s 100 × 70
614 56 15 L.s 36 × 33 ×
15 R.s 24 × 23 ×
715 77 108* L.s 116 mm
108* R.s 54 mm
816 28 12 L.s NA
36 R.s NA
Our case 48 24 L.s 80 × 50 ×
2 R.s 75 × 45 ×
* Associated with hydrocele. L lymph node dissection, L.s left side, NA not available
right side.confirmed it by histology [28]. The authors identified
three types of cells, with a preponderance of medium-
sized cells present in a clear background; low mitotic rate
and absence of lymphocytes were also noted in aspir-
ational smears. Lopez and Aranda also concluded FNACof bilateral SS
ong axis Treatment Follow-up (months) Outcome
Surveillance 121 NRD
× 60 mm RO 10 NRD
30 mm RO
25 mm, 52 g RO + C 12 NRD
30 mm, 57 g RO + C
40 mm, 64 g RO + L 48 NRD
27 mm, 67 g RO
33 mm, 210 g RO + R 44 NRD
× 35 mm, 390 g RO + R
30 mm, 65 g RO 6 NRD
25 mm, 53 g RO




45 mm, 108 g RO 18 NRD
40 mm, 118 g RO
, NRD no recurrence of disease, R radiotherapy, RO radical orchiectomy, R.s
Xu et al. World Journal of Surgical Oncology 2013, 11:175 Page 5 of 6
http://www.wjso.com/content/11/1/175was a simple diagnostic procedure for providing the con-
firmative diagnosis of SS [29]. In our patient, preoperative
diagnosis was also a challenge as the aspirational fluids
were so scarce that cytological testing was obscure with
only a few malignant cells found.
Radical orchiectomy via an inguinal approach followed
by adjuvant is a typical malignant testicular tumor ther-
apy treatment. Although sporadic cases of metastatic SS
have been reported, SS is an indolent neoplasm that
rarely metastasizes and bears an excellent prognosis
[10]. Hence, orchiectomy alone is indicated for treat-
ment. However, when sarcomatous dedifferentiation is
involved, aggressive behavior, presence of metastasis or
poor outcome may result. A handful of SS cases have
been described that have transformed to rhabdomyosar-
coma [7,21,22]. In such settings, adjuvant chemotherapy
and radiotherapy may be beneficial. In bilateral SS cases,
one case underwent chemotherapy and two received
radiotherapy after orchiectomy [14,15]. There was only
one patient who received no intervention except surveil-
lance. With a median follow-up of 36.8 months (range 6
to 121 months), no patient has relapsed. Post-orchiectomy
surveillance comprising 6-monthly chest radiographs and
tumor maker assays for the first 3 years in our practice
should be advocated.Conclusions
SS is a rare testicular tumor, with bilateral sequential SS
presentation being even more rare. It differs from clas-
sical seminoma especially by its behavior, characterized
by an almost complete inability to metastasize with only
very few examples described with metastatic behavior.
FNAC is a procedure used for precluding malignant tu-
mors. However, histopathology is essential to confirm the
diagnosis. In spite of scarce evidence of bilateral SS metas-
tasis, long-term periodic surveillance remains necessary.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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